RST-Sanexas produces several different models for treating acute and chronic pain, severe neuropathic pain, as well as most physical medicine and rehabilitation conditions. Patented, communications-level technology includes new Electronic Signal Intonation (ESI) for unprecedented patient outcomes.
Electric cell signaling treatment (EST) refers to the use of electronic
signal energy waves produced by an ultra-high digital frequency
generator (UHdfg). These therapeutic pulsed energy waves are
comfortably and non-invasively delivered directly into the body’s
desired anatomical region.
The neoGEN-Series® signal energy waves, along with associated harmonic resonance frequencies, are used to physiologically imitate, exhaust or block certain functions of the amacrine, somatic or sympathetic nerve fibers for comprehensive patient treatment success. Even newer research involving electric signal energy waves with expanded and sweeping frequency at a quarter-tone scale rate are referred to as electric cell intonation (ESI). The neoGEN-Series® system is a state-of-the art, technically-innovative medical device for producing electric cell signaling energy waves (EST and ESI). The system is used to successfully treat circulatory issues, all types of acute and chronic pain, long-term (intractable) pain and drug-resistant pain. The neoGEN-Series® also offers specific-parameter signaling for efficacious neuro-muscular reeducation, muscle strengthening and relaxation of muscle spasm activity.
The neoGEN-Series® system has numerous published medical journal
reports and studies involving the successful treatment of multiple medical
indications, syndromes and neurogenic pain conditions.
The neoGEN-Series® system is the original (and only) EST medical system that was clinically utilized with the documented and published Combined Electrochemical Treatment (CET) protocol. Copies of published research
are available upon written request.